Upregulaton of ATAD2 in cancer tissues compared to paired normal tissues has been reported previously in multiple cancers, such as renal cell carcinoma 22, breast cancer 23 and prostate cancer 24. Here, ATAD2 is linked to renal cell carcinoma.